These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15975516)

  • 1. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.
    Jo E; Sanna MG; Gonzalez-Cabrera PJ; Thangada S; Tigyi G; Osborne DA; Hla T; Parrill AL; Rosen H
    Chem Biol; 2005 Jun; 12(6):703-15. PubMed ID: 15975516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off the shelf but not mass produced.
    Karliner JS
    Chem Biol; 2005 Jun; 12(6):614-5. PubMed ID: 15975506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.
    Sobel K; Menyhart K; Killer N; Renault B; Bauer Y; Studer R; Steiner B; Bolli MH; Nayler O; Gatfield J
    J Biol Chem; 2013 May; 288(21):14839-51. PubMed ID: 23589284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice.
    Bolick DT; Srinivasan S; Kim KW; Hatley ME; Clemens JJ; Whetzel A; Ferger N; Macdonald TL; Davis MD; Tsao PS; Lynch KR; Hedrick CC
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):976-81. PubMed ID: 15761190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells.
    Schaper K; Kietzmann M; Bäumer W
    Mol Immunol; 2014 May; 59(1):10-8. PubMed ID: 24434636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate signaling in physiology and diseases.
    Takuwa Y; Okamoto Y; Yoshioka K; Takuwa N
    Biofactors; 2012; 38(5):329-37. PubMed ID: 22674845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-dependent effects of mutations in the sphingosine-1-phosphate type 1 receptor.
    van Loenen PB; de Graaf C; Verzijl D; Leurs R; Rognan D; Peters SL; Alewijnse AE
    Eur J Pharmacol; 2011 Sep; 667(1-3):105-12. PubMed ID: 21663738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics.
    Gonzalez-Cabrera PJ; Hla T; Rosen H
    J Biol Chem; 2007 Mar; 282(10):7254-64. PubMed ID: 17218309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
    Clemens JJ; Davis MD; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3568-72. PubMed ID: 15982878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR).
    Baudhuin LM; Jiang Y; Zaslavsky A; Ishii I; Chun J; Xu Y
    FASEB J; 2004 Feb; 18(2):341-3. PubMed ID: 14657000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions.
    Gollmann G; Neuwirt H; Tripp CH; Mueller H; Konwalinka G; Heufler C; Romani N; Tiefenthaler M
    Int Immunol; 2008 Jul; 20(7):911-23. PubMed ID: 18495625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S1P1 receptor localization confers selectivity for Gi-mediated cAMP and contractile responses.
    Means CK; Miyamoto S; Chun J; Brown JH
    J Biol Chem; 2008 May; 283(18):11954-63. PubMed ID: 18296752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 Activation.
    Messias CV; Santana-Van-Vliet E; Lemos JP; Moreira OC; Cotta-de-Almeida V; Savino W; Mendes-da-Cruz DA
    PLoS One; 2016; 11(1):e0148137. PubMed ID: 26824863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
    Krump-Konvalinkova V; Chwalla I; Siess W
    Biochem Biophys Res Commun; 2008 Jun; 370(4):603-8. PubMed ID: 18402775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells.
    Tanimoto T; Lungu AO; Berk BC
    Circ Res; 2004 Apr; 94(8):1050-8. PubMed ID: 15044318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration.
    Bergelin N; Löf C; Balthasar S; Kalhori V; Törnquist K
    Endocrinology; 2010 Jul; 151(7):2994-3005. PubMed ID: 20501673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
    Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening.
    Schürer SC; Brown SJ; Gonzalez-Cabrera PJ; Schaeffer MT; Chapman J; Jo E; Chase P; Spicer T; Hodder P; Rosen H
    ACS Chem Biol; 2008 Aug; 3(8):486-98. PubMed ID: 18590333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses.
    Wei SH; Rosen H; Matheu MP; Sanna MG; Wang SK; Jo E; Wong CH; Parker I; Cahalan MD
    Nat Immunol; 2005 Dec; 6(12):1228-35. PubMed ID: 16273098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.